ATE112487T1 - Pharmazeutische zubereitung. - Google Patents

Pharmazeutische zubereitung.

Info

Publication number
ATE112487T1
ATE112487T1 AT91301566T AT91301566T ATE112487T1 AT E112487 T1 ATE112487 T1 AT E112487T1 AT 91301566 T AT91301566 T AT 91301566T AT 91301566 T AT91301566 T AT 91301566T AT E112487 T1 ATE112487 T1 AT E112487T1
Authority
AT
Austria
Prior art keywords
atenolol
aspirin
pharmaceutical preparation
capsule
absorbtion
Prior art date
Application number
AT91301566T
Other languages
English (en)
Inventor
William Byrne
Andrew Rynne
Olive Corrigan
Original Assignee
Byrne Rynne Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byrne Rynne Holdings Ltd filed Critical Byrne Rynne Holdings Ltd
Application granted granted Critical
Publication of ATE112487T1 publication Critical patent/ATE112487T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91301566T 1990-02-26 1991-02-26 Pharmazeutische zubereitung. ATE112487T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE67590A IE64128B1 (en) 1990-02-26 1990-02-26 A pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE112487T1 true ATE112487T1 (de) 1994-10-15

Family

ID=11016623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91301566T ATE112487T1 (de) 1990-02-26 1991-02-26 Pharmazeutische zubereitung.

Country Status (9)

Country Link
US (1) US5156849A (de)
EP (1) EP0449426B1 (de)
AT (1) ATE112487T1 (de)
DE (1) DE69104396T2 (de)
DK (1) DK0449426T3 (de)
ES (1) ES2063446T3 (de)
GB (1) GB2241168A (de)
IE (1) IE64128B1 (de)
ZA (1) ZA911404B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003421A2 (en) * 1992-07-30 1994-02-17 Cal International Limited Esters and combinations of an organic nitrate and a salicylate
GB2284763B (en) * 1992-07-30 1996-08-28 Cal Int Ltd Pharmaceutical capsule containing an organic nitrate and a salicylate
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
JPH09508378A (ja) * 1994-01-28 1997-08-26 シーエーエル・インターナショナル・リミテッド エステル化可能なβ遮断薬のサリチレートを含む医薬製造物
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US20040198839A1 (en) * 2000-08-23 2004-10-07 Dean Herbert M. Cardioprotective dosage units
US20020077348A1 (en) * 2000-11-21 2002-06-20 Dean Herbert M. Dosage unit for cardioprotection
AU2012349771A1 (en) * 2011-12-09 2014-07-03 Wockhardt Limited Methods for treating cardiovascular disorder

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575775A (de) * 1958-02-18
US2965541A (en) * 1959-06-22 1960-12-20 Upjohn Co 17alpha-acetoxyprogesterone compositions for oral use and methods of using same
ES300432A1 (es) * 1963-06-04 1964-11-16 Abbott Lab Procedimiento para producir una composición analgésica
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
GB1276089A (en) * 1968-08-23 1972-06-01 Pfizer Ltd Pharmaceutical preparations
GB1204580A (en) * 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
FR2319346A1 (fr) * 1975-07-31 1977-02-25 Wellcome Found Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole
FR2368272A1 (fr) * 1976-10-20 1978-05-19 Theramex Compositions therapeutiques solides pour combattre l'agregation plaquettaire
US4464377A (en) * 1977-06-22 1984-08-07 BLANCHARD Jean Anti-thrombotic therapeutic compositions
FR2447192A1 (fr) * 1979-01-25 1980-08-22 Adria Lab Inc Forme galenique a liberation prolongee d'indoprofene
FR2469923A1 (fr) * 1979-11-26 1981-05-29 Ile De France Nouveau medicament a base d'aspirine et d'heptaminol
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
JPS59131355A (ja) * 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
FR2539989B1 (fr) * 1983-01-28 1985-08-09 Sanofi Sa Medicament a liberation programmee associant l'acide acetylsalicylique a la dihydroergotamine
FR2589358B1 (fr) * 1985-07-30 1987-12-04 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'aspirine
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
DE3535950A1 (de) * 1985-10-09 1987-04-09 Basf Ag Kombinationspraeparat
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet

Also Published As

Publication number Publication date
DK0449426T3 (da) 1994-10-31
EP0449426A1 (de) 1991-10-02
DE69104396D1 (de) 1994-11-10
IE64128B1 (en) 1995-07-12
DE69104396T2 (de) 1995-02-09
ZA911404B (en) 1991-11-27
US5156849A (en) 1992-10-20
EP0449426B1 (de) 1994-10-05
GB9103946D0 (en) 1991-04-10
GB2241168A (en) 1991-08-28
IE900675A1 (en) 1991-08-28
ES2063446T3 (es) 1995-01-01

Similar Documents

Publication Publication Date Title
DE68904801D1 (de) Waesserige pharmazeutische ueberzuege fuer dosierformen.
GB9501785D0 (en) Esters and combinations of an organic nitrate and a salicylate
DE69627817D1 (de) Pharmazeutische zubereitung, die fenofibrat und polyglykolisierte glyceride enthält
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
GB1509979A (en) Pharmaceutical compositions containing aspirin or indomethacin
AR243375A1 (es) Preparacion farmaceutica, capsula de gelatina con revestimiento enterico. procedimiento y aparato.
ES2097155T3 (es) Forma de dosificacion efervescente y metodo de administracion.
IT8921132A0 (it) Inalatore per medicamenti in capsule.
NO163356C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament.
IT9047659A0 (it) Composizione farmaceutica contenente ranitidina sotto forma di capsule di gelatina.
DE69104396D1 (de) Pharmazeutische Zubereitung.
FI913479L (fi) Menetelmä sukralfaattia sisältävien purutablettien tai -rakeiden muodossa olevan farmaseuttisen valmisteen valmistamiseksi
DE3789258D1 (de) Multigranuläre Tablette mit verzögerter Freisetzung.
ES2051658T3 (es) Comprimidos efervescentes faciles de administrar.
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
DE69105134D1 (de) Pharmazeutische zusammensetzung.
DE69122229D1 (de) Penciclovir enthaltende pharmazeutische formulierung
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
ATA321188A (de) Pharmazeutische zubereitung
DK273688A (da) Laegemiddelpakning
FI944229A0 (fi) Astyylisalisyylihappoon tai sen suoloihin perustuva puristettu farmaseuttinen annosmuoto oraalista antoa varten ja menetelmä sen valmistamiseksi
DE69324776D1 (de) Pharmazeutische Zusammensetzung die krebserkennende Antikörper enthält
IT1244037B (it) Forma farmaceutica a rilascio selettivo nel colon
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.